Skip to main content
Home
  • Solutions

    Solutions

    Our solutions span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.

    Read more
    Cardiac Safety Monitoring Clinical & Scientific Operations Consulting Early Clinical Laboratories Language Services Medical Imaging Site & Patient Solutions Strategic Solutions Symphony Health Technologies
    decentralised-hybrid-trials.jpg
    Decentralised Clinical Trial Solutions

    End-to-end services, operational model and technology to deliver customised solutions.

    real-world-intelligence.jpg
    Real World Intelligence®

    Optimising real world data to drive effective outcomes and achieve regulatory authorisation.

  • Sectors

    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read More
    Biosimilars Biotech Government and Public Health Medical Device Pharmaceuticals
    biotech-collegesinlab.jpg
    Biotech

    Developing transformative therapies requires a flexible approach.

    icon-and-you-mdd.jpg
    ICON and You

    Partners making a difference.

  • Therapeutics

    Therapeutics

    We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators.

    Read More
    Cardiovascular Cell and Gene Therapies Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Medical Device Oncology Paediatrics Rare & Orphan Diseases Transplant Immunology Women's Health
    infectious-diseases-cells-blue-graphic-image.jpg
    Vaccines

    ICON has lead the development of 18 vaccines resulting in FDA/EMA approvals, including the world’s first approved vaccine for COVID-19.

    cells-menu-hero.jpg
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights

    Insights

    BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.

    Read More
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    Patient-Diversity-Insights_Banner.jpg
    Diversity and inclusion in clinical trials

    Establishing a platform for improvement

    8001-Decentralised-hybrid-trials-MDD-(1).jpg
    Decentralised clinical trials

    Patient focused research for better outcomes.

  • News & Events

    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read More
    Press releases In the News Mediakit Awards Events Webinars Social media
    CMC-solutions-under-cGMP.jpg
    Webinar: Best practices for the validation of hybrid LC-MS/MS assays

    30 November 2023

    clinical-outcomes-assessments.jpg
    Webinar: An overview of clinical outcomes assessments and why training matters

    5 December 2023

  • About ICON

    About ICON

    Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

    Read More
    Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality
    esg-mdd.jpg
    Environmental, Social and Governance

    ICON CARES is our commitment to making a positive impact on our people, environment and our community.

    healthcare-intelligence-video-poster.png
    Healthcare Intelligence

    Clinical Research. Evolved.

  • Careers
  • Investors
  • Investigators
  • Patients
  • Contact
  • 日本語
  • 简体中文

Pushing boundaries in idiopathic pulmonary fibrosis clinical research

Read the whitepaper

COVID-19 vaccines: Post-authorisation safety surveillance

Challenges in assessing long term effects of COVID vaccines

Read the whitepaper

Navigating the regulatory labyrinth of technology in decentralised clinical trials

Read the whitepaper

EMA guideline on computerised systems and electronic data in clinical trials

Read the whitepaper

Exploring partnership culture and its impact on outsourcing and operational strategy

Actionable insights, proven strategies, and expert recommendations.

Procedural and regulatory know-how for China biotechs in the EU

How to navigate European Medicines Agency registration and regulation.

Considerations for DTx clinical trials in CNS indications

Successful digital therapeutic clinical trials.

Approaching the CAR T-cell therapy horizon

Clinical advancements expanding the potential of CAR T-cell therapies.

Featured Solutions

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Early Clinical and Bioanalytical Solutions

Innovative early clinical solutions that will advance your drug development strategy.

Medical Imaging

Expert medical imaging solutions for all stages of clinical research enabling improved decision making, increased efficiency and reduced trial costs.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Market Access

Expertise in mission-critical pricing, market access, and reimbursement. 

Functional outsourcing

ICON is the world's largest provider of FSP services.

Webinars

An overview of clinical outcomes assessments and why training matters

5 December 2023. Register now.

Artificial Intelligence at ICON

Watch the webinar.

Beyond the Token: Why Your Healthcare Data and Integration Strategy Matters

Watch the webinar.

ICON Insights

  • 16 Nov 2023

Continuing the fight against AMR with new tools for diagnosis and treatment

Read more
  • 08 Nov 2023

The impact of paediatric medical trauma in clinical trials

Read more
  • 26 Oct 2023

Navigating CTIS: Setting up clinical trials under EU CTR

Read more
  • 11 Oct 2023

Digital therapeutics considerations for CNS

Read more
  • 06 Oct 2023

Expanding CAR T-cell Therapy into solid tumours

Read more
  • 06 Oct 2023

Keeping up to date with the latest regulatory developments for decentralised clinical trials

Read more
  • 28 Sep 2023

Realising the benefits of bringing decentralised cardiovascular trials to patients

Read more
  • 22 Aug 2023

Highlights from the revised Medicare Drug Price Negotiation program guidance

Read more
  • 21 Aug 2023

CMS Medicare Part D Price Negotiations

Read more

What’s happening in ICON

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Social media dashboard
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2023 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies

How can we help?

  • All
  • Website
  • Documents
  • Videos
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption